Urogen Pharma Ltd

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$46.96

+1.36 (+2.98%)

As of Aug 8, 10:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target -3.4% upside

Low Target $37.53

Average Target $45.36

High Target $61.85

Current Price $46.96

Current
$46.96

Target
$45.36

$37.53 $45.36 avg $61.85

Scenario Analysis

Bear Case

$37.53

-20.1%

Low target

Base Case

$45.36

-3.4%

Avg target

Bull Case

$61.85

+31.7%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$48.03

-2.2% from high

52-Week Low

$15.86

+196.1% from low

Target vs 52W High

$45.36

-5.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%